Stale terms, scheduled reset: the existing book is priced for a world that has moved on
The model's full reasoning — Q3 2022 call → NOWe need to determine if management describes a meaningful portion of existing business being carried at prices/terms below current market, and that this existing business is coming up for repricing/renewal/reset on a schedule already visible, so economics improve as older terms roll off without needing new customers. Look for statements about existing contracts, pricing actions, resets, etc. The transcript discusses medical segment inflation, pricing actions taken, and future pricing. Mike Kaufmann says: "we have implemented a series of initial customer price increases on nine Cardinal Health brand product categories. We've also implemented fee increases for certain medical national brands suppliers... We have and will continue to be transparent and fair with customers and suppliers... As it relates to our products and distribution contracts, we are focusing on future pricing flexibility for factors beyond our control." Also mentions "various waves of price increases going into effect throughout the year" and "we anticipate a run rate where our pricing actions will offset approximately half of the gross impact." But is this about existing business resetting? They are taking price increases on existing products/categories. They mention "initial customer price increases" and "fee increases" - these are on existing business. They also mention "future pricing flexibility" in contracts. However, the question asks if the existing book is carried at prices below current market and will reset on a schedule. The transcript indicates they are implementing price increases now, and more will go into effect. They expect to offset half of gross impact by end of fiscal '23. This suggests they are raising prices on existing business, not just new. But is it a "meaningful portion" and is it a reset of existing contracts? They say "we have implemented a series of initial customer price increases on nine Cardinal Health brand product categories" - that's existing products. They also mention "we are focusing on future pricing flexibility" - that's for future contracts. The improvement is from price increases they are taking, not from contracts rolling over.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SNV | Synovus Financial Corp. | Q1 2024 | 2024-04-18 | B |
| FISI | Financial Institutions, Inc. | Q4 2023 | 2024-01-26 | B |
| UMBF | UMB Financial Corporation | Q3 2022 | 2022-10-26 | C+ |
| CRK | Comstock Resources, Inc. | Q2 2022 | 2022-08-02 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| DBX | Dropbox, Inc. | Q2 2018 | 2018-08-09 | B |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
FISI · Q4 2023 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market terms, and that it's coming up for repricing on a visible schedul...YES The transcript shows management describing exactly this situation for the company's existing loan and securities portfolios (yields rolling off) and for a meaningful portion of its deposit book (the money-market campaign with 12-month guarantees that reset in July 2024). Jack Plants explicitly ties the expected margin expansion to these scheduled repric ings and redeployments of existing cash flows, stating that the improvement is already embedded in the company's current commitments and does not require new customers or demand. This matches the criteria for a "meaningful portion" of the existing business coming up for repricing on a visible schedule. The answer is therefore YES.
PTC · Q3 2017 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market prices/terms that are coming up for repricing on a visible schedu...YES Management describes a meaningful portion of the existing business (large enterprise customers on volume purchase agreements / perpetual licenses with discounted maintenance) being carried at below-current off-the-shelf rates. These older terms are expiring on a visible schedule (many in Q4 2017), creating a compelling event where customers must either convert 50%+ ACV uplift to subscription or renew maintenance at 25% higher rates. This repricing is already embedded in the existing book and will improve economics without new customers or demand, as confirmed by the large pipeline of such opportunities and the fact that most large deals are already moving to subscription.
UMBF · Q3 2022 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market terms that will reprice/reset on a known schedule, improving econ...YES The transcript shows management describing a meaningful portion of the existing loan book carried at past terms that are now below current market levels, with repricing already scheduled: 61% of loans (~$12.1 billion) are variable-rate, 60% repricing in the next quarter and 71% within 12 months, tied to short-end indices. Loan yields rose 74 bp quarter-over-quarter to 4.46% (cycle-to-date beta 37%), and the securities portfolio is rolling off at ~1.83% yield while cash flows fund higher-yielding loans.